Ex parte FALOTICO et al. - Page 6




                 Appeal No. 1997-3389                                                                                                                   
                 Application No. 08/449,956                                                                                                             


                 is unpersuasive for the reasons set forth in our decision in                                                                           
                 Appeal No. 97-3332.                                                                                                                    
                          Those reasons are repeated below for completeness.                                                                            
                          According to appellants and the Mazzola Declaration, this                                                                     
                 evidence demonstrates that a Neodol 23-3 based surfactant                                                                              
                 blend contributes improved cold water residue properties to a                                                                          
                 carbonate-based laundry detergent in comparison with a Neodol                                                                          
                 25-3 based surfactant blend as used in the working examples of                                                                         
                 the Mazzola patent.   However, appellants have failed to1                                                                                                    
                 explain how they arrived at that conclusion based on the data                                                                          
                 reported in their specification on page 18 (Example II).                                                                               
                 Appellants have the burden of explaining the relevance and                                                                             
                 significance of the data presented.  See In re Borkowski, 505                                                                          
                 F.2d 713, 719, 184 USPQ 29, 33 (CCPA 1974).                                                                                            
                          Appellants have failed to explain the relevance of the                                                                        
                 data upon which they rely.  As we see it, in comparative                                                                               
                 Example II none of the samples listed in the Table on page 18                                                                          
                 of the specification appear to correspond to either Neodol 23-                                                                         

                          1According to appellants' specification (page 8 and 11),                                                                      
                 Neodol 23-3 is a mixture of ethoxylated C C  alcohols;                                                                                 
                                                                                           12- 13                                                       
                 whereas Neodol 25-3 is a mixture of ethoxylated C -C                                                                                   
                                                                                                         12    15                                       
                 alcohols.                                                                                                                              
                                                                           6                                                                            





Page:  Previous  1  2  3  4  5  6  7  8  9  10  Next 

Last modified: November 3, 2007